Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and receptors in type 1, type 2 and type 17 inflammation in cross-sectional asthma study.
Marks M, Steele C, Moore WC, Meyers DA, Rector B, Ampleford E, Bleecker ER, Hastie AT. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and receptors in type 1, type 2 and type 17 inflammation in cross-sectional asthma study. Thorax. 2020 09; 75(9):808-811.